Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald Simon

Showing results (311-320 of 495) with videos related to

Pageof 50
Sort By:
Urologic Oncology|November 24, 2019
8p deletions in renal cell carcinoma are associated with unfavorable tumor features and poor overall survivalTill Eichenauer, David C Bannenberg, Martina Kluth, et al.
Scientific Reports|May 19, 2017
Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancerAsmus Heumann, Özge Kaya, Christoph Burdelski, et al.
Molecular Oncology|February 20, 2024
ITIH5 as a multifaceted player in pancreatic cancer suppression, impairing tyrosine kinase signaling, cell adhesion and migrationJennifer Kosinski, Antonio Sechi, Johanna Hain, et al.
International Journal of Cancer|February 6, 2013
MALDI mass spectrometric imaging based identification of clinically relevant signals in prostate cancer using large-scale tissue microarraysStefan Steurer, Carina Borkowski, Sinje Odinga, et al.
Oncotarget|November 24, 2016
Deletion of 8p is an independent prognostic parameter in prostate cancerMartina Kluth, Nina Nadine Amschler, Rami Galal, et al.
BMC Cancer|January 7, 2018
High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancerAsmus Heumann, Nina Heinemann, Claudia Hube-Magg, et al.
Scientific Reports|August 22, 2018
Author Correction: Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancerAsmus Heumann, Özge Kaya, Christoph Burdelski, et al.
World Journal of Urology|February 11, 2018
Immunohistochemically detected IDH1<sup>R132H</sup> mutation is rare and mostly heterogeneous in prostate cancerAndrea Hinsch, Meta Brolund, Claudia Hube-Magg, et al.
Cancers|June 20, 2019
Determination of PD-L1 Expression in Circulating Tumor Cells of NSCLC Patients and Correlation with Response to PD-1/PD-L1 InhibitorsMelanie Janning, Franca Kobus, Anna Babayan, et al.
Carcinogenesis|November 3, 2016
Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability and is linked to tumor aggressiveness and early PSA recurrence in prostate cancerWaldemar Wilczak, Semin Rashed, Claudia Hube-Magg, et al.
Pageof 50

Showing results (311-320 of 495) with videos related to

Sort By:
Pageof 50
Urologic Oncology|November 24, 2019
8p deletions in renal cell carcinoma are associated with unfavorable tumor features and poor overall survivalTill Eichenauer, David C Bannenberg, Martina Kluth, et al.
Scientific Reports|May 19, 2017
Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancerAsmus Heumann, Özge Kaya, Christoph Burdelski, et al.
Molecular Oncology|February 20, 2024
ITIH5 as a multifaceted player in pancreatic cancer suppression, impairing tyrosine kinase signaling, cell adhesion and migrationJennifer Kosinski, Antonio Sechi, Johanna Hain, et al.
International Journal of Cancer|February 6, 2013
MALDI mass spectrometric imaging based identification of clinically relevant signals in prostate cancer using large-scale tissue microarraysStefan Steurer, Carina Borkowski, Sinje Odinga, et al.
Oncotarget|November 24, 2016
Deletion of 8p is an independent prognostic parameter in prostate cancerMartina Kluth, Nina Nadine Amschler, Rami Galal, et al.
BMC Cancer|January 7, 2018
High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancerAsmus Heumann, Nina Heinemann, Claudia Hube-Magg, et al.
Scientific Reports|August 22, 2018
Author Correction: Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancerAsmus Heumann, Özge Kaya, Christoph Burdelski, et al.
World Journal of Urology|February 11, 2018
Immunohistochemically detected IDH1<sup>R132H</sup> mutation is rare and mostly heterogeneous in prostate cancerAndrea Hinsch, Meta Brolund, Claudia Hube-Magg, et al.
Cancers|June 20, 2019
Determination of PD-L1 Expression in Circulating Tumor Cells of NSCLC Patients and Correlation with Response to PD-1/PD-L1 InhibitorsMelanie Janning, Franca Kobus, Anna Babayan, et al.
Carcinogenesis|November 3, 2016
Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability and is linked to tumor aggressiveness and early PSA recurrence in prostate cancerWaldemar Wilczak, Semin Rashed, Claudia Hube-Magg, et al.
Pageof 50